Describing patients’ needs in the context of research priorities in patients with multiple myeloma or Waldenstrom's disease: A truly patient-driven study;Definition von Forschungsschwerpunkten bei Patienten mit multiplem Myelom oder M. Waldenström: eine wahrhaft patientengeführte Studie

Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen

Volumn 112, Issue , 2016, Pages 11-18

  van Merode, Tiny ^a   Bours, Silvia ^a   van Steenkiste, Ben ^a   Sijbers, Theo ^b   van der Hoek, Gerard ^c   Vos, Cor ^c   Bos, Gerard M J ^a   van der Weijden, Trudy ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CMWP Patient Organization   (Netherlands)

^c Foundation Fonds Stimulans   (Netherlands)

Author keywords

Cancer; Morbus Waldenstr m; multiple myeloma; oncology; patient centered care; research priorities

Indexed keywords

GERMANY; HUMAN; MEDICAL RESEARCH; MULTIPLE MYELOMA; NEEDS ASSESSMENT; NETHERLANDS; PATIENT PARTICIPATION; QUESTIONNAIRE; WALDENSTROEM MACROGLOBULINEMIA;

BIOMEDICAL RESEARCH; GERMANY; HUMANS; MULTIPLE MYELOMA; NEEDS ASSESSMENT; NETHERLANDS; PATIENT PARTICIPATION; SURVEYS AND QUESTIONNAIRES; WALDENSTROM MACROGLOBULINEMIA;

EID: 84959441483     PISSN: 18659217     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.zefq.2016.01.005     Document Type: Article

References (19)

1. [1] Abma, T.A., Broerse, J.E.W., Patient participation as dialogue: setting research agendas. Health Expectations 13:2 (2010), 160–173.
2. [2] De Wit, M.P., Berlo, S.E., Aanerud, G.J., et al. European League against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 70:5 (2011), 722–726, 10.1136/ard.2010.135129 Epub 2011 Jan 20.
3. [3] Abma, T.A., Patients as Partners in a Health Research Agenda Setting: The Feasibility of a Participatory Methodology. Eval Health Prof 29 (2006), 42–439.
4. [4] Caron-Flinterman, J.F., Broerse, J.E.W., Teerling, J., Bunders, J.F.G., Patients’ priorities concerning health research: The case of Asthma and COPD research in the Netherlands. Health Expectations 8 (2005), 253–263.
5. [5] http://www.lindalliance.org/JLA_Method.asp.
6. [6] Smith, D., Yong, K., Multiple myeloma. BMJ, 2013, 346 http://dx.doi.org/10.1136/bmj.f3863.
7. [7] http://themmrf.org/research-programs/funded-grants/.
8. [8] Kelly, M., Dowling, M., Patients’ lived experience of myeloma. Nursing Standard 25 (2011), 38–44.
9. [9] Coon, S.K., McBride-Wilson, J., Coleman, E.A., Back to basics: assessment, communication, caring and follow-up. A lesson from a couple's journey with multiple myeloma. Clinical Journal of Oncology Nursing 11 (2007), 825–829.
10. [10] Molassiotis, A., Wilson, B., Blair, S., Howe, T., Cavet, J., Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology 20 (2011), 88–97.
11. [11] Molassiotis, A., Wilson, B., Blair, S., Howe, T., Cavet, J., Living with multiple myeloma: experiences of patients and their informal caregivers. Support Care Cancer 19 (2011), 101–111.
12. [12] Mühlbacher, A.C., Lincke, H.-J., Nübling, M., Evaluating patients’ preferences for multiple myeloma therapy, a Discrete- Choice- Experiment. GMS Psycho-Social Medicine 5 (2008), 1860–5214.
13. [13] Stephens, M., The lived experience post-autologous haematopoietic stem cell transplant (HSCT): a phenomenological study. European Journal of Oncology Nursing 9 (2005), 204–215.
14. [14] Fine Dahan, J., Auerbach, C.F., A qualitative study of the trauma and posttraumatic growth of multiple myeloma patients treated with peripheral blood stem cell transplant. Palliative and Supportive Care 4 (2006), 365–387.
15. [15] Stead, M.L., Brown, J.M., Velikova, G., et al. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European organization for research and treatment of cancer study group on quality of life. Br. J. Haematol. 104 (1999), 605–611.
16. [16] Mols, F., Oerlemans, S., Vos, A.H., Koster, A., Verelst, S., Sonneveld, P., van de Poll-Franse, L.V., Health-related quality of life and disease specific complaints among multiple myeloma patients up to 10 years after diagnosis. European Journal of Haematology 89 (2012), 311–319.
17. [17] Poulos, A.R., Gertz, M.A., Pankratz, V.S., Post-White, J., Pain, Mood disturbance and Quality of Life in patients with multiple myeloma. ONF 28 (2001), 1163–1171.
18. [18] Tong, A., Sainsbury, P., Carter, S.M., et al. Patients’ priorities for health research: focus group study of patients with chronic kidney research. Nephrol Dial Transplant 23 (2008), 3206–3214.
19. [19] Sonneveld, P., Jongen, J.P.L., Dealing with Neuropathy in Plasma-Cell Dyscrasias. Hematology, 2010 no 1, 423–430.